@kateemerson88 a study published in the lancet showed lower % efficacy (protection from symptomatic disease) with shorter gaps between az doses.

&lt;6wks 55.1%
6-8wks 59.9%
9-11wks 63.7%
&gt;12wks 81.3%

https://t.co/9nisevdayi